Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 1.00 |
| ▸ | ACHE | P22303 | 4/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 4/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.84 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.84 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.72 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.69 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.69 |
| ▸ | ESR1 | P03372 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | ATM | Q13315 | 1/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.65 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.64 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nymphaeol A SCHEMBL16105856 | 1.00 | ELANE (1.00) | ELANEACHEPTGS2ALOX5TP53 | |
| Nymphaeol A SCHEMBL909988 | 1.00 | ELANE (1.00) | ELANEACHEPTGS2ALOX5TP53 | |
| Nymphaeol A SCHEMBL30637584 | 1.00 | ELANE (1.00) | ELANEACHEPTGS2ALOX5TP53 | |
| Nymphaeol A SCHEMBL30532526 | 1.00 | ELANE (1.00) | ELANEACHEPTGS2ALOX5TP53 | |
| Nymphaeol A SCHEMBL909992 | 1.00 | ELANE (1.00) | ELANEACHEPTGS2ALOX5TP53 | |
| SCHEMBL16105743 | 0.99 | ELANE (0.98) | ELANEACHEPTGS2ALOX5TP53 | |
| SCHEMBL3238475 | 0.99 | ELANE (0.98) | ELANEACHEPTGS2ALOX5TP53 | |
| SCHEMBL12909498 | 0.99 | ELANE (0.98) | ELANEACHEPTGS2ALOX5TP53 | |
| SCHEMBL26621041 | 0.93 | ELANE (0.86) | ELANEACHEPTGS2ALOX5TP53 | |
| SCHEMBL13043321 | 0.93 | ELANE (0.86) | ELANEACHEPTGS2ALOX5TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2783684-B1 | PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES | NATUREWISE BIOTECH & MEDICALS CORP (TW) | 2018-10-03 | — | — | EP | claimed |
| US-9457007-B2 | Prenylflavanone compounds for modulating diabetes | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2016-10-04 | — | — | US | claimed |
| US-20140296543-A1 | PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2014-10-02 | — | — | US | claimed |
| EP-2783684-A1 | Prenylflavanone compounds for modulating diabetes | NatureWise Biotech & Medicals Corporation (TW) | 2014-10-01 | — | — | EP | claimed |
| EP-4577181-A1 | ORAL CARE COMPOSITIONS | Adyani Consulting Corp. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024042191-A1 | ORAL CARE COMPOSITIONS | BLISSANDMORE GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2023-04-13 | — | — | US | disclosed |
| CN-115038435-A | Composition for obesity inhibition | 株式会社大赛璐 | 2022-09-09 | — | — | CN | disclosed |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-09 | — | — | US | disclosed |
| WO-2021237371-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-02 | — | — | WO | disclosed |
| EP-3261635-B1 | BENZENE COMPOUNDS FOR TREATING OCULAR DISEASES | NATUREWISE BIOTECH & MEDICALS CORP (TW) | 2021-03-31 | — | — | EP | disclosed |
| US-20100144857-A1 | PRENYLFLAVANONE COMPOUNDS AND USES THEREOF | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2010-06-10 | — | — | US | disclosed |
| US-20100144857-A1 | PRENYLFLAVANONE COMPOUNDS AND USES THEREOF | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2010-06-10 | — | — | US | disclosed |
| US-7585892-B2 | Compound for promoting the growth of neural cells | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2009-09-08 | — | — | US | disclosed |
| US-7585892-B2 | Compound for promoting the growth of neural cells | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2009-09-08 | — | — | US | disclosed |
| US-20090076130-A1 | COMPOUNDS FOR THE INHIBITION OF HISTONE DEACETYLASE | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2009-03-19 | — | — | US | disclosed |
| US-20090076130-A1 | COMPOUNDS FOR THE INHIBITION OF HISTONE DEACETYLASE | NATUREWISE BIOTECH & MEDICALS CORPORATION (TW) | 2009-03-19 | — | — | US | disclosed |
| US-20070232534-A1 | Promote the growth of neurons, which is revealed by the increase in the thickness, length and number of branches in the neurites; stimulating the proliferation of neuron stem cells using propolin | NATUREWISE BIOTECH& MEDICALS CORPORATION (TW) | 2007-10-04 | — | — | US | disclosed |
| US-20070232534-A1 | Promote the growth of neurons, which is revealed by the increase in the thickness, length and number of branches in the neurites; stimulating the proliferation of neuron stem cells using propolin | NATUREWISE BIOTECH& MEDICALS CORPORATION (TW) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | ELANE 1548/4885ACHE 2560/4885PTGS2 2381/4885 |
| US-20100144857-A1 | PRENYLFLAVANONE COMPOUNDS AND USES THEREOF | FNTA, CYP4F2, CYP4F3 | ELANE 1512/4885ACHE 3450/4885PTGS2 599/4885 |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | ELANE 1548/4885ACHE 2560/4885PTGS2 2381/4885 |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | ADH1A, ADH1C, AHR | ELANE 1548/4885ACHE 2560/4885PTGS2 2381/4885 |
| US-20140296543-A1 | PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES | SREBF2, GID4, SREBF1 | ELANE 3443/4885ACHE 4566/4885PTGS2 559/4885 |
| US-20090076130-A1 | COMPOUNDS FOR THE INHIBITION OF HISTONE DEACETYLASE | SMN1; SMN2, HDAC1, HDAC5 | ELANE 1578/4885ACHE 913/4885PTGS2 3139/4885 |
| US-20070232534-A1 | Promote the growth of neurons, which is revealed by the increase in the thickness, length and number of branches in the neurites; stimulating the proliferation of neuron stem cells using propolin | NGF, BDNF, DCX | ELANE 3157/4885ACHE 159/4885PTGS2 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.